ArticleNeurology(R) neuroimmunology & neuroinflammation2026
Distinct Multiomic Signatures of Environmental Exposure Drive Immune Dysregulation and Disease Activity in Early Multiple Sclerosis.
Article in Neurology(R) neuroimmunology & neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesEnvironmental factors are pivotal in determining multiple sclerosis (MS) susceptibility, yet their specific influence on the immune system at the time of diagnosis remains incompletely understood. The aim of this study was to map the systemic effects of modifiable risk factors, specifically smoking, body mass index (BMI), serum vitamin D, UV exposure, and latent viral immunity, on immune function in patients with treatment-naive MS.
methodsA multiomics analysis was performed on a monocentric cohort of 96 treatment-naive patients. The study used a combination of bulk transcriptomics across 6 immune cell lineages, serum proteomics, cell-cell communication modeling, and high-dimensional flow cytometry to identify unique immunologic patterns linking environmental exposures to disease pathology.
resultsSmoking was found to induce an upregulation of the tissue-homing receptor GPR15 across lineages, particularly in NK cells, which correlated with higher disability levels. Smoking also amplified a proinflammatory milieu (increased CXCL17 and LAMP3). Higher potential UV exposure seemed to counteract these effects by lowering IFI30 and LYZ expression; notably, elevated IFI30 correlated with the presence of gadolinium-enhancing lesions. Regarding metabolic factors, high BMI exerted a linear effect on monocyte metabolism, driving cholesterol biosynthesis (MVD and SQLE) and increasing proinflammatory markers (FABP4 and LEP) associated with blood-brain barrier compromise. DISCUSSION: These findings elucidate the molecular mechanisms by which modifiable risk factors contribute to MS pathology. The data imply distinct clinical approaches for risk management: while smoking cessation must likely be absolute to reverse pathogenic trafficking signals (such as GPR15 upregulation), the linear effect of BMI suggests that incremental weight loss confers proportional immunologic benefits. These insights strongly support the integration of lifestyle interventions as a core component of early MS management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.